This Clorox Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

TD Cowen analyst Robert Moskow upgraded the rating for The Clorox Company CLX from Sell to Hold and raises the price target from $155 to $170. Clorox shares closed at $162.42 on Tuesday. See how other analysts view this stock.
Barclays analyst Trevor Young upgraded Revolve Group, Inc. RVLV from Underweight to Equal-Weight and raised the price target from $17 to $25. Revolve shares closed at $26.02 on Tuesday. See how other analysts view this stock.
Leerink Partners analyst Rick Bienkowski upgraded the rating for Beam Therapeutics Inc. BEAM from Market Perform to Outperform and increased the price target from $27 to $39. Beam Therapeutics shares closed at $23.93 on Tuesday. See how other analysts view this stock.
Deutsche Bank analyst David Begleiter upgraded Celanese Corporation CE from Hold to Buy and lowered the price target from $135 to $110. Celanese shares closed at $91.00 on Tuesday. See how other analysts view this stock.

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Considering buying CLX stock? Here’s what analysts think: